Question 1

What are the potential benefits of combining golimumab with methotrexate compared to methotrexate alone?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Treatment With Golimumab in Early PsA clinical trial (NCT01871649). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Treatment With Golimumab in Early PsA clinical trial (NCT01871649). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with golimumab and methotrexate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Treatment With Golimumab in Early PsA clinical trial (NCT01871649). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial, and what will my visits look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Treatment With Golimumab in Early PsA clinical trial (NCT01871649). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks involved in stopping treatment with golimumab after the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Treatment With Golimumab in Early PsA clinical trial (NCT01871649). Contact the study team or your healthcare provider for specific answers.

What this study is about